Day One Biopharmaceuticals (DAWN) Return on Capital Employed: 2024-2025
Historic Return on Capital Employed for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2025 value amounting to -0.36%.
- Day One Biopharmaceuticals' Return on Capital Employed rose 10.00% to -0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.36%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.54% for FY2024, which is 8.00% up from last year.
- According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Return on Capital Employed is -0.36%, which was down 53.23% from -0.24% recorded in Q2 2025.
- Day One Biopharmaceuticals' 5-year Return on Capital Employed high stood at -0.24% for Q2 2025, and its period low was -1.08% during Q2 2024.
- In the last 2 years, Day One Biopharmaceuticals' Return on Capital Employed had a median value of -0.42% in 2024 and averaged -0.52%.
- Data for Day One Biopharmaceuticals' Return on Capital Employed shows a peak YoY soared of 85bps (in 2025) over the last 5 years.
- Over the past 2 years, Day One Biopharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.42% in 2024, then rose by 10bps to -0.36% in 2025.
- Its last three reported values are -0.36% in Q3 2025, -0.24% for Q2 2025, and -0.38% during Q1 2025.